BIND THERAPEUTICS INC's ticker is BINDQXXXX and the CUSIP is 05548N107. A total of 37 filers reported holding BIND THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $9,778,000 | -79.8% | 25,000 | +13.6% | 0.01% | -89.4% |
| Q1 2016 | $48,400,000 | -63.8% | 22,000 | -26.7% | 0.08% | -77.3% |
| Q3 2015 | $133,800,000 | +91.5% | 30,000 | +140.0% | 0.37% | +350.6% |
| Q2 2015 | $69,875,000 | +69.7% | 12,500 | +66.7% | 0.08% | +144.1% |
| Q1 2015 | $41,175,000 | – | 7,500 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 155,000 | $2,123,500,000 | 1.67% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 604,207 | $8,426,000 | 0.50% |
| BVF INC/IL | 150,000 | $2,264,000 | 0.40% |
| EMERALD ADVISERS, LLC | 419,752 | $6,334,000 | 0.34% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 256,384 | $3,869,000 | 0.20% |
| Alyeska Investment Group, L.P. | 62,087 | $937,000 | 0.04% |
| THOMPSON DAVIS & CO., INC. | 1,500 | $23,000 | 0.04% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 13,000 | $196,000 | 0.03% |
| SSI INVESTMENT MANAGEMENT LLC | 23,580 | $356,000 | 0.03% |
| TFS CAPITAL LLC | 20,933 | $316,000 | 0.02% |